New report urges more clinical trial diversity, recommends incentives

Regulatory NewsRegulatory NewsAPIsBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsCombination products/companion diagnosticsDiagnostics/IVDsEthicsMedical DevicesNorth AmericaOTCPharmaceuticalsPreclinical studyRegulatory Intelligence/PolicyResearch, Design and Development